Status of α-emitter Radioimmunoconjugates for Targeted Therapy

被引：0
|
作者：
Mobina, Rabiei [1 ]
Alaei, Ahmad Reza Vaez [2 ]
Yousefnia, Hassan [3 ]
机构：
[1] Islamic Azad Univ, Nucl Engn Sch, Shahrood Branch, Shahrud, Iran
[2] Islamic Azad Univ, Parand Branch, Fac Sci, Tehran, Iran
[3] Nucl Sci & Technol Res Inst NSTRI, Radiat Applicat Res Sch, Tehran, Iran
来源：
CURRENT RADIOPHARMACEUTICALS | 2023年 / 16卷 / 02期
关键词：
& alpha; -emitters; radio; immunotherapy; immunoconjugates; bifunctional ligands; trials; MONOCLONAL-ANTIBODY; IN-VITRO; ALPHA-RADIOIMMUNOTHERAPY; MURINE MODEL; CANCER; ASTATINE-211; DOSIMETRY; FRAGMENTS; LYMPHOMA; F(AB')2;
D O I：
10.2174/1874471016666230106111119
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This minireview describes the global situation of ongoing research and development and the clinical application of alpha emitter labeled immunoconjugates with various alpha emitters with an overview of the future trends. The potentially helpful alpha emitter radioisotopes for medical applications, chelators, and immunomolecules of interest for future alpha radioimmunotherapy are discussed. Challenges and some suggested future works on chelators are also presented.
引用
收藏
页码：85 / 94
页数：10
相关论文
共 50 条
  • [31] Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma
    Zhang, Ganghua
    Chen, Xinyu
    Fang, Jianing
    Tai, Panpan
    Chen, Aiyan
    Cao, Ke
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] CURRENT STATUS OF TARGETED THERAPY IN NON-SMALL CELL LUNG CANCER
    Parums, D. V.
    DRUGS OF TODAY, 2014, 50 (07) : 503 - 525
  • [33] Smart Nanocarriers for Targeted Cancer Therapy
    Martinelli, Chiara
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (05) : 546 - 557
  • [34] Hydrogel systems for targeted cancer therapy
    Li, Xinlin
    Xu, Xinyi
    Xu, Mengfei
    Geng, Zhaoli
    Ji, Ping
    Liu, Yi
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [35] Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy
    Guo, Yuan-yuan
    Huang, Lu
    Zhang, Zhi-ping
    Fu, De-hao
    CURRENT MEDICAL SCIENCE, 2020, 40 (03) : 463 - 473
  • [36] Radionuclides for Targeted Therapy: Physical Properties
    Stokke, Caroline
    Kvassheim, Monika
    Blakkisrud, Johan
    MOLECULES, 2022, 27 (17):
  • [37] Targeted radionuclide therapy: frontiers in theranostics
    Gallivanone, Francesca
    Valente, Mauro
    Savi, Annarita
    Canevari, Carla
    Castiglioni, Isabella
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2017, 22 : 1750 - 1759
  • [38] Targeted therapy of patients with urothelial carcinoma
    Slavyanskaya, Tatiana
    Salnikova, Svetlana
    Avdonkina, Natalia
    Sepiashvili, Revaz
    Baldueva, Irina
    ALLERGY, ASTHMA & IMMUNOPHYSIOLOGY: INNOVATIVE TECHNOLOGIES, 2016, : 281 - 288
  • [39] Targeted therapy
    Catena, Laura
    TUMORI JOURNAL, 2010, 96 (05): : 861 - 865
  • [40] New insights into affinity proteins for HER2-targeted therapy: Beyond trastuzumab
    Akbari, Vajihe
    Chou, C. Perry
    Abedi, Daryoush
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (02):
12345